Condition: Human Papillomavirus Infection · Sponsor: Universiteit Antwerpen
The aim of this study is to develop robust analytical protocols for the monitoring of vaccine induced immunity against the Human Papillomavirus (HPV) in first-void urine samples and to examine fluctuations of urinary HPV-specific antibodies and potential normalization markers in different cohorts.
This description comes directly from the study's public registry record.
Alex Vorsters, Professor · +3232659130 · alex.vorsters@uantwerpen.be
Margo Bell · +32476014843 · margo.bell@uantwerpen.be
Always discuss trial participation with your own doctor first.
| University of Antwerp | Edegem, Antwerp, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06582654